Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
17.07
+0.12 (0.71%)
At close: Jan 8, 2026, 4:00 PM EST
17.39
+0.32 (1.87%)
After-hours: Jan 8, 2026, 7:40 PM EST
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $2.67 billion as of January 8, 2026. Its market cap has decreased by -13.81% in one year.
Market Cap
2.67B
Enterprise Value
1.84B
1-Year Change
-13.81%
Ranking
Category
Stock Price
$17.07
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $2.67B, an increase of 41.25%. That is a compound annual growth rate of 4.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 2.49B | 2.66% |
| Dec 31, 2025 | 2.42B | -17.45% |
| Dec 31, 2024 | 2.93B | -1.10% |
| Dec 29, 2023 | 2.97B | -21.48% |
| Dec 30, 2022 | 3.78B | -30.66% |
| Dec 31, 2021 | 5.45B | -45.77% |
| Dec 31, 2020 | 10.04B | 500.42% |
| Dec 31, 2019 | 1.67B | -14.73% |
| Dec 31, 2018 | 1.96B | 42.57% |
| Dec 29, 2017 | 1.38B | -27.09% |
| Dec 8, 2017 | 1.89B | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.84B |
| Johnson & Johnson | 498.53B |
| AbbVie | 411.05B |
| UnitedHealth Group | 309.54B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.49B |
| Merck & Co. | 269.61B |
| Novo Nordisk | 254.60B |